WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
The provider will decide the dose, injection site, and schedule
Low Dose (200300mcg/day) At the standard aod 9604 dosage range, the side effect profile is minimal
How can a laboratory select and use a pathway probe with enough confidence that observed biology is not simply an artifact of concentration drift, stability behavior, solvent mismatch, or assay interference
Men with gallbladder history or known gallstones should discuss this risk with providers before starting treatment
B12 Injections might be right for you